de Almeida Pondé Robério Amorim
Secretaria de Estado da Saúde -SES/Superintendência de Vigilância em Saúde-SUVISA/GO, Gerência de Vigilância Epidemiológica de Doenças Transmissíveis-GVEDT/Coordenação de Análises e Pesquisas-CAP, Goiânia, Goiás, Brazil.
, Rua 136 Qd F44 Lt 22/24 Ed. César Sebba- Setor Sul, Goiânia, Goiás, 74-093-250, Brazil.
Mol Biol Rep. 2025 Feb 4;52(1):195. doi: 10.1007/s11033-025-10278-9.
Hepatitis B virus surface antigen (HBsAg), IgM and IgG antibodies to hepatitis B virus core antigen (anti-HBcIgM and anti-HBcIgG) comprise serological markers of hepatitis B virus (HBV) infection of great importance in the epidemiological surveillance of hepatitis B, since they have been routinely considered for classifying the acute and chronic clinical forms of HBV infection. This classification is established according to the expression and dynamics of these markers in the infected person's bloodstream, which serves as the basis for the differential diagnosis between the two clinical entities. However, in certain circumstances, both acute and chronic infection, the detection of these markers may not occur in the bloodstream, favoring the occurrence of atypical serological profiles of infection, and compromising the correct infection clinical classification. In addition, the complex and varied nature of hepatitis B serological profiles may compromise the health professional's ability to analyze the case and, thus, correctly classify the infection's clinical form. Since the expression of these markers in the bloodstream occurs dynamically, with consequent changes in the patient's serological profile as he progresses towards recovery or chronicity, the diagnosis of acute or chronic infection may also be compromised, if it is established based on the collection of a single sample and without knowing the patient's clinical history and their epidemiological antecedents. This manuscript addresses the sensitivity and specificity of HBsAg, anti-HBcIgM, and anti-HBcIgG serological markers detection in the clinical classification of HBV infection and in the epidemiological surveillance of hepatitis B. This review is covering the clinical and epidemiological interpretations of the markers in and of themselves, not in reference to any specific assays.
乙型肝炎病毒表面抗原(HBsAg)、抗乙型肝炎病毒核心抗原的IgM和IgG抗体(抗-HBcIgM和抗-HBcIgG)构成了乙型肝炎病毒(HBV)感染的血清学标志物,在乙型肝炎的流行病学监测中具有重要意义,因为它们一直被常规用于对HBV感染的急性和慢性临床形式进行分类。这种分类是根据这些标志物在感染者血液中的表达和动态变化来确定的,这是区分这两种临床实体的诊断基础。然而,在某些情况下,无论是急性感染还是慢性感染,这些标志物在血液中可能无法检测到,这有利于出现非典型的感染血清学特征,并影响感染临床分类的正确性。此外,乙型肝炎血清学特征的复杂性和多样性可能会影响卫生专业人员分析病例的能力,从而影响对感染临床形式的正确分类。由于这些标志物在血液中的表达是动态变化的,随着患者康复或转为慢性,其血清学特征也会随之改变,如果仅根据采集的单个样本进行诊断,且不了解患者的临床病史及其流行病学史,那么急性或慢性感染的诊断也可能受到影响。本手稿探讨了HBsAg、抗-HBcIgM和抗-HBcIgG血清学标志物检测在HBV感染临床分类和乙型肝炎流行病学监测中的敏感性和特异性。本综述涵盖了这些标志物本身的临床和流行病学解释,而非参考任何特定检测方法。